INS and breast cancer: These studies in post-menopausal women provide evidence that metabolic dysfunction, rather than BMI may be a better predictor of breast cancer risk; additional studies are needed to evaluate the potential relationship between metabolic dysfunction, insulin, and breast cancer risk in premenopausal women.